Association of Serum 25-Hydroxyvitamin D Concentration with Breast Cancer Risk in Postmenopausal Women in the US

Overview

Journal J Pers Med

Date 2022 Jun 24

PMID 35743729

Authors

Vijay Ganji

Layan Sukik

Bushra Hoque

Linda Boutefnouchet

Zumin Shi

Affiliations

Soon will be listed here.

Abstract

The association between serum 25-hydroxyvitamin D [25(OH)D] concentration and breast cancer risk in postmenopausal women is not well understood. The aim of this study was to investigate the association between serum 25(OH)D concentration and breast cancer in postmenopausal women in the United States using nationally representative sample surveys. We used the data from seven cycles of National Health and Nutrition Examination Surveys from 2001 to 2014. Participants were non-institutionalized postmenopausal women (n = 8108). In restricted cubic spline analysis, a significant, nonlinear, invert ‘U’ relationship was observed between serum 25(OH)D concentrations and breast cancer in postmenopausal women (p = 0.029). Overall, breast cancer risk was highest (OR = 1.5) between 70 nmol/L and 80 nmol/L of serum 25(OH)D concentration. Then after serum 25(OH)D 80 nmol/L concentration, the breast cancer risk declined. In multivariate-adjusted logistic regression, the risk of having breast cancer was significantly higher in serum 25(OH)D 75−˂100 nmol/L category compared to the 25(OH)D < 30 nmol/L category [OR and 95% CI: 2.4 (1.4−4.0)]. In conclusion, serum vitamin D concentrations ≥ 100 nmol/L are associated with reduced risk of breast cancer in postmenopausal women. Controlled trials are required to verify if serum 25(OH)D ≥ 100 nmol/L offers protection against breast cancer in postmenopausal women.

Citing Articles

Dual effect of vitamin D on breast cancer-associated fibroblasts.

Labedz N, Anisiewicz A, Stachowicz-Suhs M, Banach J, Klopotowska D, Maciejczyk A BMC Cancer. 2024; 24(1):209.

PMID: 38360633 PMC: 10868064. DOI: 10.1186/s12885-024-11961-z.

Calcitriol promotes M2 polarization of tumor-associated macrophages in 4T1 mouse mammary gland cancer via the induction of proinflammatory cytokines.

Stachowicz-Suhs M, Labedz N, Anisiewicz A, Banach J, Klopotowska D, Milczarek M Sci Rep. 2024; 14(1):3778.

PMID: 38355711 PMC: 10866890. DOI: 10.1038/s41598-024-54433-x.

Hypovitaminosis D and Metabolic Syndrome in Postmenopausal Women.

Abuhijleh H, Alkhatib D, Ganji V Healthcare (Basel). 2022; 10(10).

PMID: 36292473 PMC: 9602081. DOI: 10.3390/healthcare10102026.

Modulation of Fibroblast Activity via Vitamin D Is Dependent on Tumor Type-Studies on Mouse Mammary Gland Cancer.

Labedz N, Stachowicz-Suhs M, Psurski M, Anisiewicz A, Banach J, Piotrowska A Cancers (Basel). 2022; 14(19).

PMID: 36230508 PMC: 9559296. DOI: 10.3390/cancers14194585.

References

Ganji V, Tangpricha V, Zhang X . Serum Vitamin D Concentration ≥75 nmol/L Is Related to Decreased Cardiometabolic and Inflammatory Biomarkers, Metabolic Syndrome, and Diabetes; and Increased Cardiorespiratory Fitness in US Adults. Nutrients. 2020; 12(3). PMC: 7146199. DOI: 10.3390/nu12030730. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

Farnik H, Bojunga J, Berger A, Allwinn R, Waidmann O, Kronenberger B . Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients. Hepatology. 2013; 58(4):1270-6. DOI: 10.1002/hep.26488. View

Song D, Deng Y, Liu K, Zhou L, Li N, Zheng Y . Vitamin D intake, blood vitamin D levels, and the risk of breast cancer: a dose-response meta-analysis of observational studies. Aging (Albany NY). 2019; 11(24):12708-12732. PMC: 6949087. DOI: 10.18632/aging.102597. View

Magro G, Salvatorelli L, Puzzo L, Piombino E, Bartoloni G, Broggi G . Practical approach to diagnosis of bland-looking spindle cell lesions of the breast. Pathologica. 2020; 111(4):344-360. PMC: 8145669. DOI: 10.32074/1591-951X-31-19. View

Fedirko V, Torres-Mejia G, Ortega-Olvera C, Biessy C, Angeles-Llerenas A, Lazcano-Ponce E . Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Cancer Causes Control. 2012; 23(7):1149-62. DOI: 10.1007/s10552-012-9984-z. View

Amir E, Cecchini R, Ganz P, Costantino J, Beddows S, Hood N . 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1. Breast Cancer Res Treat. 2012; 133(3):1077-88. PMC: 3396331. DOI: 10.1007/s10549-012-2012-x. View

Wang Q, Ma A, Gao T, Liu Y, Ren L, Han L . Poor Vitamin D Status in Active Pulmonary Tuberculosis Patients and Its Correlation with Leptin and TNF-α. J Nutr Sci Vitaminol (Tokyo). 2019; 65(5):390-398. DOI: 10.3177/jnsv.65.390. View

Wilson E, Bristol M, Di X, Maltese W, Koterba K, Beckman M . A switch between cytoprotective and cytotoxic autophagy in the radiosensitization of breast tumor cells by chloroquine and vitamin D. Horm Cancer. 2011; 2(5):272-85. PMC: 3277402. DOI: 10.1007/s12672-011-0081-7. View

10.

Li S, Ou Y, Zhang H, Zhang Z, Zhou H, Liu L . Vitamin D status and its relationship with body composition, bone mineral density and fracture risk in urban central south Chinese postmenopausal women. Ann Nutr Metab. 2014; 64(1):13-9. DOI: 10.1159/000358340. View

11.

Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese L . Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer. 2010; 10:483. PMC: 2945944. DOI: 10.1186/1471-2407-10-483. View

12.

Wang J, Eliassen A, Spiegelman D, Willett W, Hankinson S . Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study II. Cancer Causes Control. 2014; 25(7):819-27. PMC: 4191840. DOI: 10.1007/s10552-014-0383-5. View

13.

McCullough M, Stevens V, Patel R, Jacobs E, Bain E, Horst R . Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res. 2009; 11(4):R64. PMC: 2750126. DOI: 10.1186/bcr2356. View

14.

Looker A, Pfeiffer C, Lacher D, Schleicher R, Picciano M, Yetley E . Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008; 88(6):1519-27. PMC: 2745830. DOI: 10.3945/ajcn.2008.26182. View

15.

Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, Chang-Claude J . Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res. 2011; 13(4):R74. PMC: 3236338. DOI: 10.1186/bcr2920. View

16.

Chlebowski R, Johnson K, Lane D, Pettinger M, Kooperberg C, Wactawski-Wende J . 25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women. Maturitas. 2010; 68(1):73-8. PMC: 3860096. DOI: 10.1016/j.maturitas.2010.10.006. View

17.

Broggi G, Filetti V, Ieni A, Rapisarda V, Ledda C, Vitale E . MacroH2A1 Immunoexpression in Breast Cancer. Front Oncol. 2020; 10:1519. PMC: 7471871. DOI: 10.3389/fonc.2020.01519. View

18.

Chesney R, Rosen J, Hamstra A, Smith C, Mahaffey K, DeLuca H . Absence of seasonal variation in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer. J Clin Endocrinol Metab. 1981; 53(1):139-42. DOI: 10.1210/jcem-53-1-139. View

19.

Townsend K, Banwell C, Guy M, Colston K, Mansi J, Stewart P . Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res. 2005; 11(9):3579-86. DOI: 10.1158/1078-0432.CCR-04-2359. View

20.

Forrest K, Stuhldreher W . Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011; 31(1):48-54. DOI: 10.1016/j.nutres.2010.12.001. View